Aesthetic and Dermatology Biologics Supplier in Spokane, WA

Why physician supervision matters for medspa accounts

A medspa itself generally does not hold the NPI that Precision Biologics verifies against; the supervising physician or medical director does. Before a medspa in Spokane can open an account, we confirm that the ordering party is the licensed physician or a practice operating under that physician's direct supervision, consistent with how these products are restricted to licensed clinics and physicians rather than sold to the public.

Documentation a dermatology or medspa practice should request

The same documentation applies whether the end use is in a dermatology office, a plastic surgery practice, or a medspa: a certificate of analysis for the lot being purchased, a donor eligibility summary, and a lot release record. For exosome products, full characterization data, including the analytical methods used and the markers identified, is available to verified accounts rather than published generally, since specifications vary by lot.

• Certificate of analysis
• Donor eligibility summary
• Lot release record
• Full ingredient disclosure for lyophilized exosome formats

Shipping and storage for aesthetic practices in the West region

Cryopreserved products arrive overnight on dry ice and need immediate transfer to -80 degree C storage; lyophilized formats are shelf-stable and easier to stock in a practice without cryogenic freezer space. A Spokane practice choosing between formats should weigh its existing cold-chain capacity against how it plans to log inventory by lot, since every product is tracked at the patient-record level once it is used.

Verifying your account

Account setup requires an NPI number for the supervising physician and takes place before pricing is shared, since pricing is never published and is available only to verified accounts. Once verified, a practice can request a peer-to-peer conversation with Precision Biologics about documentation, not clinical protocols.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.